Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Acta Neurologica Scandinavica. Supplementum
|
July 2, 2009
The histopathology of grey matter demyelination in multiple sclerosis
L Bø
Neuropathology and Applied Neurobiology
|
December 1, 1992
An immunohistochemical study of mononuclear cells in meningiomas
L Bø, S J Mørk, H Nyland
European Journal of Neurology
|
November 14, 2015
Disease-modifying treatments for multiple sclerosis - a review of approved medications
Ø Torkildsen, K-M Myhr, L Bø
Acta Neurologica Scandinavica. Supplementum
|
January 3, 2013
Polyunsaturated fatty acids in multiple sclerosis therapy
S Wergeland, Ø Torkildsen, L Bø, et al.
Acta Neurologica Scandinavica. Supplementum
|
June 18, 2008
The cuprizone model for demyelination
O Torkildsen, L A Brunborg, K-M Myhr, et al.
Acta Neurologica Scandinavica. Supplementum
|
November 30, 2012
Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review
H M B Lunde, B Bjorvatn, K-M Myhr, et al.
Immunology
|
August 1, 1994
HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro
E Ulvestad, K Williams, L Bø, et al.
Journal of the Neurological Sciences
|
October 1, 1991
Mast cells in brains during experimental allergic encephalomyelitis in Lewis rats
L Bø, T Olsson, H Nyland, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 21, 2003
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration
L Bø, C A Vedeler, H Nyland, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
April 23, 2018
The economic impact of multiple sclerosis to the patients and their families in Norway
B Svendsen, N Grytten, L Bø, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Acta Neurologica Scandinavica. Supplementum
|
July 2, 2009
The histopathology of grey matter demyelination in multiple sclerosis
L Bø
Neuropathology and Applied Neurobiology
|
December 1, 1992
An immunohistochemical study of mononuclear cells in meningiomas
L Bø, S J Mørk, H Nyland
European Journal of Neurology
|
November 14, 2015
Disease-modifying treatments for multiple sclerosis - a review of approved medications
Ø Torkildsen, K-M Myhr, L Bø
Acta Neurologica Scandinavica. Supplementum
|
January 3, 2013
Polyunsaturated fatty acids in multiple sclerosis therapy
S Wergeland, Ø Torkildsen, L Bø, et al.
Acta Neurologica Scandinavica. Supplementum
|
June 18, 2008
The cuprizone model for demyelination
O Torkildsen, L A Brunborg, K-M Myhr, et al.
Acta Neurologica Scandinavica. Supplementum
|
November 30, 2012
Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review
H M B Lunde, B Bjorvatn, K-M Myhr, et al.
Immunology
|
August 1, 1994
HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro
E Ulvestad, K Williams, L Bø, et al.
Journal of the Neurological Sciences
|
October 1, 1991
Mast cells in brains during experimental allergic encephalomyelitis in Lewis rats
L Bø, T Olsson, H Nyland, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 21, 2003
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration
L Bø, C A Vedeler, H Nyland, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
April 23, 2018
The economic impact of multiple sclerosis to the patients and their families in Norway
B Svendsen, N Grytten, L Bø, et al.
Page
of 2